February 22, 2017 2:45 AM ET


Company Overview of Axxima Pharmaceuticals AG

Company Overview

As of March 2, 2005, Axxima Pharmaceuticals AG was acquired by GPC Biotech AG. Axxima Pharmaceuticals focuses on the application of pathogen-host signal transduction intervention. The Company develops proprietary drugs that are based on Axxima's approach to generate a Signal Transduction Firewall™ (STF™) against pathogens. Axxima has developed a technology platform directed towards the identification of 'critical' interaction points between a pathogen and target cells in the host. The Company develops small molecule drugs to interfere at these critical interaction points, thus blocking the pathogen's manipulation of the host cell and leaving the pathogen without the tools with which to estab...

Am Klopfersitz 19

Martinsried,  82152


Founded in 1998


49 89 740 16 50


49 89 740 15 420

Key Executives for Axxima Pharmaceuticals AG

Axxima Pharmaceuticals AG does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
3B Pharmaceuticals GmbH Europe
Accelsiors Group International Europe
Aenova Group GmbH Europe
Aenova Holding GmbH Europe
AiCuris GmbH & Co. KG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Axxima Pharmaceuticals AG, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.